Cargando…

PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target

Microglia are the immune effector cells of the brain playing critical roles in immune surveillance and neuroprotection in healthy conditions, while they can sustain neuroinflammatory and neurotoxic processes in neurodegenerative diseases, including Parkinson’s disease (PD). Although the precise trig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lind-Holm Mogensen, Frida, Scafidi, Andrea, Poli, Aurélie, Michelucci, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111685/ https://www.ncbi.nlm.nih.gov/pubmed/37072827 http://dx.doi.org/10.1186/s12974-023-02776-z

Ejemplares similares

PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases
por: Pap, Domonkos, et al.
Publicado: (2022)

Novel Insights into PARK7 (DJ-1), a Potential Anti-Cancer Therapeutic Target, and Implications for Cancer Progression
por: Jin, Wook
Publicado: (2020)

Mitochondrial LonP1 protease is implicated in the degradation of unstable Parkinson's disease-associated DJ-1/PARK 7 missense mutants
por: Sánchez-Lanzas, Raúl, et al.
Publicado: (2021)

Special Issue “Microglia Heterogeneity and Its Relevance for Translational Research”
por: Michelucci, Alessandro, et al.
Publicado: (2021)

Differential effect of DJ-1/PARK7 on development of natural and induced regulatory T cells
por: Singh, Yogesh, et al.
Publicado: (2015)

Knockdown of the DJ-1 (PARK7) gene sensitizes pancreatic cancer to erlotinib inhibition
por: He, Xiangyi, et al.
Publicado: (2021)

Maternal PARK7 (DJ-1) levels and the preterm premature rupture of membranes: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Protective function of DJ-1/PARK7 in lipopolysaccharide and ventilator-induced acute lung injury
por: Amatullah, Hajera, et al.
Publicado: (2020)

The Tale of DJ-1 (PARK7): A Swiss Army Knife in Biomedical and Psychological Research
por: Sun, Mo E., et al.
Publicado: (2023)

Elucidating tumour‐associated microglia/macrophage diversity along glioblastoma progression and under ACOD1 deficiency
por: Pires‐Afonso, Yolanda, et al.
Publicado: (2022)

DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives
por: Repici, Mariaelena, et al.
Publicado: (2019)

DJ-1 (Park7) affects the gut microbiome, metabolites and the development of innate lymphoid cells (ILCs)
por: Singh, Yogesh, et al.
Publicado: (2020)

The role of DJ-1 complexes and catecholamine metabolism: relevance for familial and idiopathic Parkinson’s disease
por: Piston, Dominik, et al.
Publicado: (2018)

The Role of DJ-1 in Cellular Metabolism and Pathophysiological Implications for Parkinson’s Disease
por: Mencke, Pauline, et al.
Publicado: (2021)

6-Hydroxydopamine induces secretion of PARK7/DJ-1 via autophagy-based unconventional secretory pathway
por: Urano, Yasuomi, et al.
Publicado: (2018)

Oxidative Neurodegeneration Is Prevented by UCP0045037, an Allosteric Modulator for the Reduced Form of DJ-1, a Wild-Type of Familial Parkinson’s Disease-Linked PARK7
por: Yamane, Koichiro, et al.
Publicado: (2009)

The Glymphatic System (En)during Inflammation
por: Mogensen, Frida Lind-Holm, et al.
Publicado: (2021)

Neuroprotective Function of DJ-1 in Parkinson's Disease
por: Ariga, Hiroyoshi, et al.
Publicado: (2013)

Inhibitors of lysosomal function or serum starvation in control or LAMP2 deficient cells do not modify the cellular levels of Parkinson disease-associated DJ-1/PARK 7 protein
por: Sánchez-Lanzas, Raúl, et al.
Publicado: (2018)

Correction: Inhibitors of lysosomal function or serum starvation in control or LAMP2 deficient cells do not modify the cellular levels of Parkinson disease-associated DJ-1/PARK 7 protein
por: Sánchez-Lanzas, Raúl, et al.
Publicado: (2020)

Upregulation of DJ-1 in Dopaminergic Neurons by a Physically-Modified Saline: Implications for Parkinson’s Disease
por: Jana, Malabendu, et al.
Publicado: (2023)

DJ-1 Variants in Indian Parkinson’s Disease Patients
por: Sadhukhan, Tamal, et al.
Publicado: (2012)

Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease
por: Dolgacheva, Ludmila P., et al.
Publicado: (2019)

Relevance of chronic stress and the two faces of microglia in Parkinson’s disease
por: Herrera, Antonio J., et al.
Publicado: (2015)

Life-time expression of the proteins peroxiredoxin, beta-synuclein, PARK7/DJ-1, and stathmin in the primary visual and primary somatosensory cortices in rats
por: Böhm, Michael R. R., et al.
Publicado: (2015)

The association between increased maternal PARK7 (DJ-1) levels and the occurrence of preterm premature rupture of membranes - A randomized prospective study
por: Turhan, Uğur, et al.
Publicado: (2021)

DJ-1 Mutations are Rare in a Swedish Parkinson Cohort
por: Anvret, Anna, et al.
Publicado: (2011)

Oxidized DJ-1 as a possible biomarker of Parkinson’s disease
por: Saito, Yoshiro
Publicado: (2014)

Salivary DJ-1 could be an indicator of Parkinson's disease progression
por: Kang, Wen-Yan, et al.
Publicado: (2014)

Microglia in Health and Disease: The Strength to Be Diverse and Reactive
por: Uriarte Huarte, Oihane, et al.
Publicado: (2021)

Cellular and Molecular Characterization of Microglia: A Unique Immune Cell Population
por: Sousa, Carole, et al.
Publicado: (2017)

Microglia in Health and Disease: A Unique Immune Cell Population
por: Michelucci, Alessandro, et al.
Publicado: (2018)

Cytoprotective Mechanisms of DJ-1: Implications in Cardiac Pathophysiology
por: Tsoporis, James N., et al.
Publicado: (2021)

Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma
por: Pires-Afonso, Yolanda, et al.
Publicado: (2020)

Heritability Enrichment Implicates Microglia in Parkinson’s Disease Pathogenesis
por: Andersen, Maren Stolp, et al.
Publicado: (2021)

DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease
por: Lin, Xiangmin, et al.
Publicado: (2012)

Increased DJ-1 in Urine Exosome of Korean Males with Parkinson's Disease
por: Ho, Dong Hwan, et al.
Publicado: (2014)

Methylation status of DJ-1 in leukocyte DNA of Parkinson’s disease patients
por: Tan, Yuyan, et al.
Publicado: (2016)

Parkinsonism-Associated Protein DJ-1 Is an Antagonist, Not an Eraser, for Protein Glycation
por: Gao, Qingzeng, et al.
Publicado: (2023)

Mice With a Combined Deficiency of Superoxide Dismutase 1 (Sod1), DJ-1 (Park7), and Parkin (Prkn) Develop Spontaneous Retinal Degeneration With Aging
por: Zhu, Yuanfei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aho4u5v06r22m3jl56v3en68q3